Puneet Souda
Stock Analyst at Leerink Partners
(1.98)
# 3,002
Out of 5,182 analysts
197
Total ratings
48.17%
Success rate
-1.18%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Upgrades: Outperform | $12 → $25 | $9.00 | +177.78% | 11 | Apr 29, 2026 | |
| GH Guardant Health | Maintains: Outperform | $170 → $180 | $91.17 | +97.43% | 8 | Feb 20, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $545 → $580 | $462.60 | +25.38% | 20 | Oct 22, 2025 | |
| CYRX Cryoport | Upgrades: Outperform | $16 | $10.21 | +56.71% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $6.55 | +83.21% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $3.37 | +137.39% | 12 | Apr 30, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $4.94 | +325.10% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $33.45 | +19.58% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $211.56 | -29.10% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $301.88 | +24.22% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $25.52 | +37.15% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $112.18 | +29.26% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $174.04 | +72.37% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $139.37 | +79.38% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $54.74 | +100.95% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $118.21 | +69.19% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.59 | +292.16% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.41 | +325.53% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $56.19 | -46.61% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $36.39 | +139.08% | 13 | May 5, 2022 |
NeoGenomics
Apr 29, 2026
Upgrades: Outperform
Price Target: $12 → $25
Current: $9.00
Upside: +177.78%
Guardant Health
Feb 20, 2026
Maintains: Outperform
Price Target: $170 → $180
Current: $91.17
Upside: +97.43%
Thermo Fisher Scientific
Oct 22, 2025
Maintains: Outperform
Price Target: $545 → $580
Current: $462.60
Upside: +25.38%
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $10.21
Upside: +56.71%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $6.55
Upside: +83.21%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $3.37
Upside: +137.39%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $4.94
Upside: +325.10%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $33.45
Upside: +19.58%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $211.56
Upside: -29.10%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $301.88
Upside: +24.22%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $25.52
Upside: +37.15%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $112.18
Upside: +29.26%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $174.04
Upside: +72.37%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $139.37
Upside: +79.38%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $54.74
Upside: +100.95%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $118.21
Upside: +69.19%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.59
Upside: +292.16%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.41
Upside: +325.53%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $56.19
Upside: -46.61%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $36.39
Upside: +139.08%